CBD and Trazodone
What we know about combining cannabidiol with the sleep and antidepressant drug trazodone — mostly theoretical risks and very little direct evidence.
There is almost no direct human research on combining CBD and trazodone. What we do have is solid pharmacology: CBD inhibits several liver enzymes (CYP3A4, CYP2D6) that also metabolize trazodone, so combining them can raise trazodone levels and side effects — sedation, dizziness, low blood pressure, and rare heart-rhythm issues. If you take trazodone for sleep or depression, don't stack CBD on top without telling your prescriber. That's the whole honest answer.
Plain-language summary
Trazodone is an older antidepressant that is now prescribed far more often off-label for insomnia at low doses (25–100 mg at bedtime) [1]. CBD (cannabidiol) is a non-intoxicating cannabinoid sold as a supplement and, in one form (Epidiolex), as a prescription anti-seizure drug [2].
People often ask about combining them for two reasons: they want better sleep, or they already take trazodone and are curious whether CBD is safe to add. The short answer: no controlled study has tested this combination in humans. What we know comes from how each drug is broken down in the liver, and from the known side-effect profiles of each. Both are sedating. CBD also slows down enzymes that clear trazodone, which can raise trazodone blood levels Weak / limited.
This article is not medical advice. Talk to the prescriber who put you on trazodone before adding CBD, and don't stop trazodone abruptly.
What probably works
Nothing about the combination has been shown to work better than either drug alone. This section is intentionally short because the honest answer is: there is no good evidence that adding CBD to trazodone improves sleep, mood, or anxiety beyond what trazodone alone does No data.
What is reasonably well established, separately:
- Low-dose trazodone modestly improves sleep onset and continuity in some patients with insomnia, though the evidence base is smaller than for other hypnotics [1][3] Weak / limited.
- High-dose oral CBD (hundreds of mg/day) has strong evidence for reducing seizures in specific pediatric epilepsy syndromes [2] Strong evidence.
- CBD's effects on sleep and anxiety at typical over-the-counter doses (10–50 mg) are inconsistent across trials [4] Weak / limited.
What might work (weak or theoretical)
Some people report that low-dose CBD helps them fall asleep and feel less anxious, and trazodone is often used for the same reason. In theory, combining them could be additive. In practice, that additive effect is just as likely to show up as excessive next-day grogginess, dizziness on standing, or dry mouth as it is as "better sleep" Anecdote.
CBD has been studied for generalized anxiety and PTSD-related sleep disturbance in small open-label trials, with modest positive signals [5] Weak / limited. None of these trials included patients on trazodone, so we cannot extrapolate to the combination.
What doesn't work or has weak evidence
- Using CBD to "replace" trazodone. There is no head-to-head trial. Stopping trazodone abruptly can cause rebound insomnia and, rarely, discontinuation symptoms [1] Weak / limited. Do not swap without a prescriber's plan.
- Using CBD to reduce trazodone side effects. No evidence supports this No data. If anything, CBD may amplify sedation and orthostatic hypotension.
- Assuming "natural" means "no interaction." CBD has documented, clinically meaningful drug interactions — this is not folklore. The Epidiolex label specifically warns about CYP-mediated interactions [2][6] Strong evidence.
The pharmacokinetic interaction
Trazodone is metabolized primarily by CYP3A4, with a smaller contribution from CYP2D6. Its active metabolite mCPP is cleared by CYP2D6 [7].
CBD is a documented inhibitor of CYP3A4, CYP2C19, CYP2C9, and CYP2D6 at concentrations achievable with oral dosing [6][8] Strong evidence (mechanistic). Co-administration would be expected to:
- Slow trazodone clearance, raising peak and trough levels.
- Slow clearance of mCPP, which is associated with anxiety, nausea, and dysphoria at higher levels [7].
The magnitude of this interaction in real patients has not been directly measured. Effects are likely larger with high-dose oral CBD (e.g., 300+ mg/day, as in Epidiolex) than with typical supplement doses (10–50 mg) Weak / limited. Inhaled CBD produces lower systemic and portal-vein exposure and probably causes less enzyme inhibition, though this has not been formally studied for trazodone.
Risks and side effects to watch
Realistic risks when combining CBD and trazodone:
- Additive sedation and next-day impairment. Both drugs are sedating; combined use can affect driving and coordination [1][4] Weak / limited.
- Orthostatic hypotension. Trazodone lowers blood pressure on standing, especially in older adults. Falls are a documented harm [1] Strong evidence.
- QT prolongation. Trazodone carries a modest QT-prolongation risk [1]. CBD has not been clearly shown to prolong QT, but caution is warranted if you have cardiac risk factors Disputed.
- Serotonin syndrome. Trazodone is serotonergic. CBD is not directly serotonergic in a clinically significant way, so the combination alone is low risk, but stacking other serotonergic agents (SSRIs, tramadol, triptans, MDMA) raises risk [1] Weak / limited.
- Priapism. Trazodone has a rare but serious risk of priapism. There is no evidence CBD changes this risk No data.
- Liver enzymes. High-dose CBD can elevate liver transaminases, especially with other hepatically metabolized drugs [2] Strong evidence.
Comparison with standard sleep and depression treatments
For insomnia, first-line evidence supports cognitive behavioral therapy for insomnia (CBT-I) over any drug, including trazodone [3][9] Strong evidence. If a drug is used, options with more insomnia-specific evidence include low-dose doxepin, melatonin receptor agonists, and dual orexin antagonists. Trazodone is widely used off-label largely because it is cheap and non-scheduled, not because it has the strongest evidence [3].
For depression, trazodone is a reasonable but not first-line antidepressant; SSRIs and SNRIs generally have better tolerability at therapeutic doses [1]. CBD is not an evidence-based treatment for depression No data. Do not substitute CBD for a prescribed antidepressant.
What we don't know
- The actual magnitude of the CBD–trazodone pharmacokinetic interaction in humans has never been measured.
- Whether low-dose CBD (under 50 mg/day) meaningfully changes trazodone levels.
- Whether inhaled or sublingual CBD interacts less than oral CBD with trazodone specifically.
- Whether CBD offers any additive benefit for trazodone-treated insomnia or depression.
- Long-term safety of chronic co-administration.
If you take trazodone and want to try CBD, the honest move is: tell your prescriber, start low, avoid high-dose oral CBD, and watch for excess sedation, dizziness, or morning hangover. See also CBD Drug Interactions and Cannabis and Sleep.
Not medical advice
This article summarizes publicly available evidence and is not medical advice. It is not a substitute for a conversation with a licensed clinician who knows your history. Do not start, stop, or change the dose of trazodone or any other prescription drug based on what you read here. If you experience chest pain, fainting, a sustained erection lasting more than four hours (priapism), or signs of serotonin syndrome (agitation, high fever, rapid heart rate, muscle rigidity), seek emergency care.
Sources
- Government U.S. Food and Drug Administration. Trazodone hydrochloride tablets — prescribing information.
- Government U.S. Food and Drug Administration. Epidiolex (cannabidiol) oral solution — prescribing information.
- Peer-reviewed Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innovations in Clinical Neuroscience, 2017;14(7-8):24-34.
- Peer-reviewed Kaul M, Zee PC, Sahni AS. Effects of cannabinoids on sleep and their therapeutic potential for sleep disorders. Neurotherapeutics, 2021;18(1):217-227.
- Peer-reviewed Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in anxiety and sleep: a large case series. The Permanente Journal, 2019;23:18-041.
- Peer-reviewed Brown JD, Winterstein AG. Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use. Journal of Clinical Medicine, 2019;8(7):989.
- Peer-reviewed Fagiolini A, Comandini A, Catena Dell'Osso M, Kasper S. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs, 2012;26(12):1033-1049.
- Peer-reviewed Bansal S, Maharao N, Paine MF, Unadkat JD. Predicting the potential for cannabinoids to precipitate pharmacokinetic drug interactions via reversible inhibition or inactivation of major cytochromes P450. Drug Metabolism and Disposition, 2020;48(10):1008-1017.
- Peer-reviewed Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 2016;165(2):125-133.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.